Investigating the Burden of Pseudomonas aeruginosa Infections in COVID Patients and Resistance Profiles in Abbottabad, Pakistan
Abstract
Nosocomial infections are a great menace for hospitalized patients and Pseudomonas aeruginosa has emerged as one of the most potent nosocomial pathogens due to its continuous emanation of multi-drug resistance. Conjointly, P. aeruginosa coinfection is a significant problem in multitudinous infections. The present study aimed to investigate the frequency and antibiotic susceptibility profile of P. aeruginosa, from the specimens isolated from patients from Ayub Teaching Hospital in Abbottabad, Pakistan. In this cross-sectional study, eighty strains of P. aeruginosa were obtained from 200 patients (urine, wounds, and pus samples), using routine microbiological methods, and antibiotic susceptibility testing was performed using the Kirby Bauer disc diffusion method. The majority of isolates (51.25%) were taken from wounds, followed by pus (38%) and urine (27.27%). Of the 80 isolates, 12 originated from individuals who were also infected with the Coronavirus (a 34% coinfection rate). These isolates were sensitive to levofloxacin (80%) and vancomycin (75%) but were resistant to moxifloxacin (80%) and amikacin (69%). P. aeruginosa is found in high frequency in clinical specimens from patients in Abbottabad, and these microorganisms are transiently resistant to routinely given antibiotics, making it critical to utilize anti-Pseudomonas medications correctly. It is concluded that the P. aeruginosa infections and resistance continued to increase owing to various intrinsic and extrinsic…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 200 participants or records.
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.